During the DLT-evaluation period (Cycle 0, Day 1 to Cycle 1, Day 21), DLT occurred in 1 patient (grade 3 pneumonia and increased ALT levels) at the beginning of Cycle 1 with DS-1205c 200 mg (cohort 1). The gene discussed is GPT; the disease is susceptibility to pneumonia measurement.